Nisa Investment Advisors
NPCE icon

Nisa Investment Advisors’s Neuropace NPCE Stock Holding History

Nisa Investment Advisors’s Portfolio NPCE Stock Details NPCE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$46.5K Sell
2,928
-125
-4% -$2.01K ﹤0.01% 1885
2026
Q1 		$40.1K Buy
3,053
+3,000
+5,660% +$45K ﹤0.01% 1762
2025
Q4 		$818 Hold
53
– – ﹤0.01% 2742
2025
Q3 		$546 Sell
53
-22
-29% -$207 ﹤0.01% 2841
2025
Q2 		$836 Buy
75
+22
+42% +$275 ﹤0.01% 2770
2025
Q1 		$651 Hold
53
– – ﹤0.01% 2743
2024
Q4 		$593 Hold
53
– – ﹤0.01% 2796
2024
Q3 		$369 Buy
+53
New +$388 ﹤0.01% 2770
2022
Q3 		– Sell
-3,000
Closed -$15K – 2623
2022
Q2 		$15K Buy
+3,000
New +$19.8K ﹤0.01% 2114

Other funds holding NPCE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
PAM
Panagora Asset Management Boston, Massachusetts $32.6B AUM 52.29% 1-Year Est. Return
LCM
Legato Capital Management San Francisco, California $1.21B AUM 82.36% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
GS
GWN Securities Palm Beach Gardens, Florida $598M AUM 32.4% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Nisa Investment Advisors's NPCE Position: Q2 2026 in Review

Nisa Investment Advisors reduced its Neuropace (NPCE) stake by 4.1% in Q2 2026, selling an estimated $2.01K and leaving 2,928 shares worth $46.5K. The position accounts for ﹤0.01% of the portfolio, ranked #1885.

Nisa Investment Advisors first reported a position in NPCE in Q2 2022 and has held it in 9 quarters since. 30 funds tracked by Wall St. Rank hold NPCE as of Q2 2026.

  • Nisa Investment Advisors held 2,928 shares of Neuropace worth $46.5K as of Q2 2026.
  • Nisa Investment Advisors sold 125 Neuropace shares in Q2 2026, an estimated $2.01K.
  • Neuropace made up ﹤0.01% of Nisa Investment Advisors's portfolio in Q2 2026, its #1885 holding.
  • Nisa Investment Advisors first reported a position in Neuropace in Q2 2022 and has held it in 9 quarters since.
  • 30 funds tracked by Wall St. Rank held Neuropace as of Q2 2026.

Based on Nisa Investment Advisors's 13F filing for Q2 2026, filed 10 Aug 2026.